Bio-Path Holdings to Announce Second Quarter 2023 Financial Results on August 15, 2023
08 8월 2023 - 8:00PM
Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology
company leveraging its proprietary DNAbilize® antisense RNAi
nanoparticle technology to develop a portfolio of targeted nucleic
acid cancer drugs, today announced that it will host a live
conference call and audio webcast on Tuesday, August 15, 2023 at
8:30 a.m. ET to report financial results for the second quarter
ended June 30, 2023 and to provide a business overview.
To access the live conference call, please call (833) 630-1956
(domestic) or (412) 317-1837 (international) at least five minutes
prior to the start time. A live audio webcast of the call will also
be available on the Presentations section of the Company’s website,
www.biopathholdings.com. An archived webcast will be available on
the Bio-Path website approximately two hours after the event.
About Bio-Path Holdings, Inc.
Bio-Path is a biotechnology company developing DNAbilize®, a
novel technology that has yielded a pipeline of RNAi
nanoparticle drugs that can be administered with a
simple intravenous transfusion. Bio-Path’s lead product
candidate, prexigebersen (BP1001, targeting the Grb2 protein),
is in a Phase 2 study for blood cancers, and BP1001-A, a
drug product modification of prexigebersen, is in a Phase 1
study for solid tumors. The Company’s second product, BP1002,
which targets the Bcl-2 protein, is being evaluated for the
treatment of blood cancers and solid tumors, including lymphoma and
acute myeloid leukemia. In addition, an IND application is
expected to be filed for BP1003, a novel liposome-incorporated
STAT3 antisense oligodeoxynucleotide developed by Bio-Path as
a specific inhibitor of STAT3.
For more information, please visit the Company's website at
http://www.biopathholdings.com.
Contact
Information: Investors
Will O’ConnorStern Investor Relations
212-362-1200will@sternir.com
Doug Morris Investor Relations Bio-Path Holdings, Inc.
832-742-1369
Bio Path (NASDAQ:BPTH)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Bio Path (NASDAQ:BPTH)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024